Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Total Liabilities (2011 - 2026)

Verastem (VSTM) posted quarterly Total Liabilities of $146.0 million for Q1 2026, down 11.03% year-over-year from $164.1 million in Q1 2025, and down 22.83% quarter-over-quarter from $189.2 million in Q4 2025.

Analysis

Verastem (VSTM) Total Liabilities (2011 - 2026) Analysis & Trends

Verastem's Total Liabilities history runs 16 years deep, the most recent figure standing at $146.0 million for Q1 2026.

  • In Q1 2026, Total Liabilities fell 11.03% year-over-year to $146.0 million; the TTM figure through Mar 2026 stood at $146.0 million (down 11.03% YoY), while the FY2025 annual figure was $189.2 million, up 45.09% from the prior year.
  • Total Liabilities for Q1 2026 stood at $146.0 million, down from $189.2 million in the prior quarter.
  • The five-year high for Total Liabilities was $192.4 million in Q3 2025, with the low at $43.4 million in Q1 2022.
  • The 5-year median for Total Liabilities is $71.8 million (2023), against an average of $99.1 million.
  • The sharpest annual moves came in 2022 and 2026: Total Liabilities soared 197.26% in 2022, then retreated 11.03% in 2026.
  • Verastem's Total Liabilities stood at $47.7 million in 2022, then surged by 49.36% to $71.2 million in 2023, then surged by 83.23% to $130.4 million in 2024, then jumped by 45.09% to $189.2 million in 2025, then dropped by 22.83% to $146.0 million in 2026.
  • Business Quant data shows VSTM's Total Liabilities at $146.0 million in Q1 2026, $189.2 million in Q4 2025, and $192.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.62 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 4.20 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 1.72 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 4.00 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 10.03 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.35 Bn
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn 156.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 156.53 Mn
Mar 31, 2026 146.03 Mn
Dec 31, 2025 189.25 Mn
Sep 30, 2025 192.38 Mn
Jun 30, 2025 160.21 Mn
Mar 31, 2025 164.13 Mn
Dec 31, 2024 130.43 Mn
Sep 30, 2024 94.16 Mn
Jun 30, 2024 65.74 Mn
Mar 31, 2024 77.32 Mn
Dec 31, 2023 71.19 Mn
Sep 30, 2023 71.81 Mn
Jun 30, 2023 69.01 Mn
Mar 31, 2023 66.69 Mn
Dec 31, 2022 47.66 Mn
Sep 30, 2022 48.22 Mn
Jun 30, 2022 46.52 Mn
Mar 31, 2022 43.38 Mn
Dec 31, 2021 21.10 Mn
Sep 30, 2021 16.22 Mn